Glen Tullman Steps Down as CEO of Allscripts (NASDAQ:MDRX)

Posted on December 19, 2012 I Written By

John Lynn is the Founder of the blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of and John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

The news is just coming out that Glen Tullman has stepped down as CEO of Allscripts (NASDAQ:MDRX) along with Allscripts President Lee Shapiro.

Paul M. Black has been selected by the Allscripts board as the new President and CEO. Mr. Black was COO at Cerner for 12 years before he retired from Cerner in 2007. He has served on the Board of The Truman Medical Centers for 12 years, most recently as Chairman, and as a director of Haemonetics Corporation (NYSE:HAE). Plus, Mr. Black is currently sitting on the board of Allscripts.

It’s an understatement to say that it’s been an incredibly tumultuous year for Allscripts. Allscripts chose to discontinue their Allscripts MyWay EHR, Allscripts sued NYC after losing an EHR deal, and then Allscripts started looking for a private equity buyer.

This latest round of firings was predicted by Anne Zieger when she wrote about the previous Allscripts Management Shakeup and the investors desire to fire Glen Tullman a while ago.

I imagine the board was waiting to see if any of the strategic alternatives (ie. Private Equity buyouts) could save Glen’s job, but Allscripts also announced that “the Board has formally concluded its evaluation of strategic alternatives.”

Usually there’s a lot of shakeup after a change like this, but Allscripts EHR users have already been through a lot. It will be interesting to see what Mr. Black does with Allscripts going forward.

Here’s the details of the Conference Call that will be held tomorrow about the changes:

Conference Call

Allscripts will conduct a conference call tomorrow, Thursday, December 20, 2012, at 8:30 AM Eastern Time to discuss today’s announcement. Investors can access the conference via the Internet at Participants also may access the conference call by dialing (877) 303-0543 (toll free in the US) or (973) 935-8787 (international) and requesting Conference ID #83012880.

A replay of the call will be available two hours after the conclusion of the call, for a period of four weeks, at or by calling (855) 859-2056 or (404) 537-3406 – Conference ID #83012880.